March 18, 2025 11:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'The controversial ruler died 300 years ago': Uddhav Thackeray questions row over Aurangzeb's tomb | Maha Kumbh showed unity in diversity: PM Modi in Parliament | Think twice before travelling outside US: Indians with H-1B, F-1 visas, green cards warned by immigration attorneys | Mamata Banerjee visits Furfura Sharif, slams Opposition for questioning her intent ahead of 2026 polls | Left, BJP call Mamata's Oxford University invitation fake PhD deja vu, TMC hits back | Violence breaks out in Nagpur over call to remove Aurangzeb's tomb, Fadnavis appeals for peace | Ballet dance between dragon, elephant is the only choice: China after Modi's 'positive' remarks in Lex Fridman podcast | PM Modi meets Tulsi Gabbard, discusses ways to enhance cooperation for tackling terrorism | Trump, Modi are focused on strengthening shared interests of India and US: Tulsi Gabbard | Orry in legal trouble for drinking at Katra hotel near Vaishno Devi pilgrimage site in Jammu and Kashmir
CBI raids DCGI's office in Delhi over alleged bribery links

CBI raids DCGI's office in Delhi over alleged bribery links

Jun 20, 2022, at 10:21 pm

Delhi: The Central Bureau of Investigation (CBI) is conducting raids at the Delhi office of the Drugs Controler General of India (DCGI) in connection with an alleged bribery case, media reported.

India poised to become 'global hub for medicines': DCGI

India poised to become 'global hub for medicines': DCGI

Apr 15, 2022, at 03:36 am

New Delhi: There has been a fourfold increase in applications of the investigational new drugs in the country, according to Dr VG Somani, Drug Controller General of India (DCGI), media reports said.

Drug regulator issues notice to Amazon, Flipkart for alleged sale of spurious cosmetics

Drug regulator issues notice to Amazon, Flipkart for alleged sale of spurious cosmetics

Nov 13, 2018, at 01:31 pm

New Delhi, Nov 13 (IBNS) :  India’s premier drug and cosmetics agency, Drug Controller General of India (DCGI) has issued notices to e-commerce giants  Flipkart and  Amazon warning against the alleged sell of "spurious and adulterated" cosmetics including imported brands, and sought a reply within ten days, media reports said.

Close menu